Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3566516 | 0.85 | GCK (0.56) | GCKKCNH2 | |
| SCHEMBL3563017 | 0.85 | GCK (0.56) | GCKKCNH2 | |
| SCHEMBL27727416 | 0.85 | GCK (0.43) | GCKKCNH2 | |
| SCHEMBL27748425 | 0.82 | GCK (0.57) | GCK | |
| SCHEMBL27727394 | 0.82 | GCK (0.67) | GCKKCNH2 | |
| SCHEMBL27727474 | 0.82 | GCK (0.53) | GCK | |
| SCHEMBL27727388 | 0.82 | GCK (0.49) | GCK | |
| SCHEMBL28764307 | 0.82 | GCK (0.40) | GCK | |
| SCHEMBL27727496 | 0.81 | GCK (0.51) | GCKKCNH2 | |
| SCHEMBL2645847 | 0.81 | GCK (0.61) | GCKKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101273015-A | 3-cyclyl-2- (4-sulfamo yl-phenyl) -N-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes | NOVARTIS AG (CH) | 2008-09-24 | — | — | CN | claimed |
| CN-101273015-A | 3-cyclyl-2- (4-sulfamo yl-phenyl) -N-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes | NOVARTIS AG (CH) | 2008-09-24 | — | — | CN | disclosed |